A previous independent study showed that CSF concentrations of soluble APPs (both sAPP-alpha and beta) were reduced in ADC patients, and that this finding helped distinguish the CSF profile of ADC from that of Alzheimer's disease [27]. This evidence concerns the gene CTSB and early-onset autosomal dominant Alzheimer disease.